Assignee
PTC THERAPEUTICS MP INC
US·11 granted patents·10 pending applications·38 citations·filing 2017–2025
Top patents by PatentIndex Score
21 records- 0196US11773097B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2021·Granted Oct 3, 2023·5 cites·17 claims
- 0294US11752154B2Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2019·Granted Sep 12, 2023·5 cites·20 claims
- 0392US11072614B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2017·Granted Jul 27, 2021·8 cites·30 claims
- 0490US11173158B2Medicinal agent and beverage/food for preventing cerebral dysfunction and improving samePTC THERAPEUTICS MP INC·Filed 2019·Granted Nov 16, 2021·8 cites·8 claims
- 0590US11130760B2Polymorphic form of sepiapterinPTC THERAPEUTICS MP INC·Filed 2017·Granted Sep 28, 2021·9 cites·18 claims
- 0684US12269829B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2023·Granted Apr 8, 2025·0 cites·14 claims
- 0783US12213982B2Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2023·Granted Feb 4, 2025·0 cites·19 claims
- 0882US11617752B2Methods for increasing sepiapterin plasma exposurePTC THERAPEUTICS MP INC·Filed 2019·Granted Apr 4, 2023·3 cites·12 claims
- 0982US2025195526A1Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2024·Application pending·0 cites
- 1079US12329757B2Methods for increasing sepiapterin plasma exposurePTC THERAPEUTICS MP INC·Filed 2023·Granted Jun 17, 2025·0 cites·6 claims
- 1172US2026091037A1Methods for increasing sepiapterin plasma exposurePTC THERAPEUTICS MP INC·Filed 2025·Application pending·0 cites
- 1272US2025230164A1Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2025·Application pending·0 cites
- 1368US12257252B2Compositions and methods for increasing tetrahydrobiopterin plasma exposurePTC THERAPEUTICS MP INC·Filed 2019·Granted Mar 25, 2025·0 cites·13 claims
- 1464US12325706B2Polymorphic form of sepiapterinPTC THERAPEUTICS MP INC·Filed 2021·Granted Jun 10, 2025·0 cites·14 claims
- 1561US2025195529A1Compositions and methods for increasing tetrahydrobiopterin plasma exposurePTC THERAPEUTICS MP INC·Filed 2025·Application pending·0 cites
- 1653US2023110351A1Methods for treating parkinson's disease with sepiapterinPTC THERAPEUTICS MP INC·Filed 2021·Application pending·0 cites
- 1753US2022362249A1Methods for treating hyperphenylalaninemiaPTC THERAPEUTICS MP INC·Filed 2020·Application pending·0 cites
- 1852US2024122931A1Methods for treating covid-19 with sepiapterinPTC THERAPEUTICS MP INC·Filed 2022·Application pending·0 cites
- 1952US2024115572A1Methods for treating glioblastomas with sepiapterinPTC THERAPEUTICS MP INC·Filed 2022·Application pending·0 cites
- 2048US2021269443A1Pharmaceutically acceptable salts of sepiapterinPTC THERAPEUTICS MP INC·Filed 2019·Application pending·0 cites
- 2144US2022273661A1Use of sepiapterin and metabolites thereof to treat radiation exposurePTC THERAPEUTICS MP INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PTC THERAPEUTICS MP INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →